Optimind Pharma (XCNQ:OMND) Additional Paid-In Capital : C$0.01 Mil(As of Nov. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Optimind Pharma Additional Paid-In Capital?

Optimind Pharma's quarterly additional paid-in capital stayed the same from May. 2024 (C$0.01 Mil) to Aug. 2024 (C$0.01 Mil) and stayed the same from Aug. 2024 (C$0.01 Mil) to Nov. 2024 (C$0.01 Mil).

Optimind Pharma's annual additional paid-in capital increased from Feb. 2022 (C$0.00 Mil) to Feb. 2023 (C$0.04 Mil) but then declined from Feb. 2023 (C$0.04 Mil) to Feb. 2024 (C$0.01 Mil).

Optimind Pharma Additional Paid-In Capital Historical Data

The historical data trend for Optimind Pharma's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimind Pharma Additional Paid-In Capital Chart

Optimind Pharma Annual Data

Trend

Feb22

Feb23

Feb24

Additional Paid-In Capital

0.04

0.01

Optimind Pharma Quarterly Data
	Jun21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24
Additional Paid-In Capital	Get a 7-Day Free Trial								0.04	0.01	0.01	0.01	0.01

Optimind Pharma Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Optimind Pharma Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Optimind Pharma's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Optimind Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimind Pharma Corp (XCNQ:OMND) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

77 King Street West, Suite 3000, TD Centre, North Tower, PO Box 95, Toronto, ON, CAN, M5K 1G8

Website

https://www.optimindpharma.com

Optimind Pharma Corp is an emerging provider of psychedelic therapies for the masses. It helps people suffering from PTSD, Anxiety, Depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities. It is also partnered with developers of psilocybin-associated treatments and products to further expand its treatment and program offerings.

Optimind Pharma Headlines

No Headlines